Study for Palmoplantar Pustulosis (72 Weeks)

Adults aged 18-75 years old with moderate to severe palmoplantar pustulosis (PPP), may qualify to participate. Individuals must have a diagnosis of PPP with persistent (more than 3 months duration), sterile, visible pustules (bumps) on the palms and/or soles, without or with plaque psoriasis elsewhere on the body. Ten (10) or more white or yellow pustules across all regions is required at screening and study entry.

Participants will receive investigational medication (active study drug) or placebo via injection. At Visit 9, those individuals who previously received placebo will then receive active study drug. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Participation will last up to 72 weeks and involve about 20 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Palmoplantar Pustulosis
Register Now!

Participating Locations


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more